Fresenius Ventures
Share
N°01 / About
About Fresenius Ventures
Fresenius has launched Fresenius Ventures, its corporate VC unit, deploying over 200 million euros over five years into healthcare adjacencies to its pharma, medtech and care-provision platforms: precision nutrition, microbiome research, new therapeutic modalities and digital care. Funded on-balance-sheet, led by ex-Angelini Ventures investor Thomas Thestrup.
N°02 / Thesis
Investment Focus
Location / RegionGermany
Funding StageSeries A
Industry Focus
Biotech
Digital Health
Investor Signals Profile
active
Sweet Spot
Healthcare-adjacency founder, EU-based, open to strategic corporate investor
7 signals on Fresenius Ventures
2 bullish · 3 pitch do's · 1 don'ts · 1 GP profile, each with its source. From €9/month, cancel anytime.
People
Key People
Thomas Michael Thestrup
Thomas Michael ThestrupManaging Director & Head